A Critical Role of miR-144 in Diffuse Large B-cell Lymphoma Proliferation and Invasion

Haiying Wang1, Aihong Wang1, Zhenbo Hu1

  • 1Department of Hematology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, China.

Cancer Immunology Research
|February 12, 2016
PubMed

Insights

MicroRNA-144 (miR-144) is downregulated in diffuse large B-cell lymphoma (DLBCL) and suppresses tumor growth by targeting BCL6. Restoring miR-144 offers a potential therapeutic strategy for DLBCL patients.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs regulate crucial biological processes, including cancer development.
  • The B-cell lymphoma 6 (BCL6) transcriptional repressor is a key therapeutic target in diffuse large B-cell lymphomas (DLBCL).
  • Mechanisms controlling BCL6 expression in DLBCL remain incompletely understood.

Purpose of the Study:

  • To investigate the role of microRNAs in regulating BCL6 expression in DLBCL.
  • To identify specific microRNAs that are dysregulated in DLBCL and correlate with BCL6 levels.
  • To evaluate the therapeutic potential of targeting identified microRNAs in DLBCL.

Main Methods:

  • Screening of microRNA expression profiles in DLBCL tissues and cell lines using quantitative reverse transcription polymerase chain reaction (qRT-PCR).
  • Validation of BCL6 as a direct target of miR-144 through analysis of 3' untranslated region (UTR) binding.
  • In vitro experiments assessing the impact of miR-144 on DLBCL cell proliferation and invasion (OCI-Ly3 cells).
  • In vivo studies using a xenograft mouse model to confirm the tumor-suppressor role of miR-144.

Main Results:

  • miR-144 expression was significantly downregulated in DLBCL specimens and cell lines.
  • A negative correlation was observed between miR-144 expression and BCL6 expression in DLBCL.
  • BCL6 was identified as a direct target of miR-144, with miR-144 suppressing BCL6 via binding to its 3' UTR.
  • Forced expression of miR-144 inhibited DLBCL cell proliferation and invasion in vitro.
  • miR-144 demonstrated a tumor-suppressive effect in vivo using a xenograft mouse model.

Conclusions:

  • miR-144 directly regulates BCL6 expression in DLBCL.
  • Downregulation of miR-144 contributes to DLBCL pathogenesis.
  • Targeting miR-144 represents a promising therapeutic strategy for DLBCL.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K